To evaluate the feasibility of using a smartphone application for monitoring and evaluation of Raynaud's Phenomenon.
Study Type
OBSERVATIONAL
Enrollment
120
use of smartphone application during 2 weeks to 3 months to collect frequency and duration of crises, RCS, photography of finger.
Chu Grenoble Alpes
Grenoble, Grenoble, France
RECRUITINGSatisfaction assessed by a 5-points Likert scales about using the application for the monitoring and evaluation of Raynaud's Phenomenon
The questionnaire assesses different items such as the ease of use of the application, the installation process on the smartphone, the use of reminders, etc. Overall satisfaction will be calculated as the non-weighted average of all items.
Time frame: 2 weeks
Relationship between cutaneous digital temperature assessed by thermography and the severity of Raynaud's Phenomenon
Correlation between digital temperature and Raynaud's Condition Score (RCS)
Time frame: 2 weeks
Relationship between cutaneous digital temperature assessed by thermography and the frequency of RP attacks
Correlation between digital temperature and the daily frequency of attacks
Time frame: 2 weeks
Relationship between cutaneous digital temperature assessed by thermography and the duration of RP attacks
Correlation between digital temperature and the cumulative daily duration of attacks
Time frame: 2 weeks
Relationship between cutaneous digital temperature assessed by thermography and pain during RP attacks
Correlation between digital temperature and pain during attacks (assessed through a 10-point VAS)
Time frame: 2 weeks
Effect of Raynaud etiology on thermographic data
Comparison of cutaneous digital temperature between patients with primary and secondary Raynaud
Time frame: 2 weeks
Effect of Raynaud treatment on thermographic data
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Comparison of cutaneous digital temperature between patients treated with calcium channel blockers and untreated patients
Time frame: 2 weeks